Activity-dependent Regulation of the Choroid Plexus-Cerebrospinal Fluid Stem Cell Niche
脉络丛-脑脊液干细胞生态位的活动依赖性调节
基本信息
- 批准号:10626875
- 负责人:
- 金额:$ 64.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAgonistApicalAxonBathingBrainBrain StemCalciumCellsCerebral cortexCerebrospinal FluidChoroid Plexus EpitheliumCouplesCuesDataDevelopmentDiffusionEmbryoEmbryonic DevelopmentEnvironmentEpithelial CellsEpitheliumFetal healthFutureG-Protein-Coupled ReceptorsGene ExpressionGene ProteinsGeneticGenetic TranscriptionGrowthHealthImageImmediate-Early GenesIn VitroIntraperitoneal InjectionsInvestigationLigandsMediatingMethodsModernizationMolecularMonitorMusNatureNeurodevelopmental DisorderNeurologicNeuronsPenetrancePeripheralPhenotypePlacentaProcessProductionProtein SecretionReceptor ActivationReceptor SignalingRegulationSalivary GlandsSerotoninSignal PathwaySignal TransductionSourceStimulusStructure of choroid plexusSurfaceTestingbrain tissuedirect applicationexperimental studyfetalgene inductionin vivoin vivo calcium imagingintraperitonealloss of functionnerve stem cellneurosteroidsnovelpostnatalreceptorresponsestem cell nichetooltranscriptometranscriptome sequencingtranscriptomicsvesicular release
项目摘要
PROJECT SUMMARY / ABSTRACT
Building the cerebral cortex requires the spatial and temporal orchestration of molecular signals across neural
progenitor cells. Each of these cells is bathed in cerebrospinal fluid (CSF), a medium rich in health- and growth-
promoting factors whose composition changes profoundly across days during brain development. The choroid
plexus (ChP) is likely to strongly contribute to this dynamic developmental regulation of CSF composition, but
the underlying mechanisms are not understood. Here, we will use a suite of modern tools to test the
hypothesis that elevations in calcium concentration in embryonic ChP epithelial cells in response to
extrinsic cues is critical for regulating synthesis and secretion of signaling factors into the CSF. Calcium
activity regulates transcription and secretion in diverse cells ranging from neurons to salivary gland epithelia. We
identified receptors expressed in ChP epithelial cells that mediate calcium entry into the cell, such as the TRPM3
receptor, or that drive calcium release from internal stores, such as the 5HT2C receptor (Htr2c) for serotonin (5-
HT, 5-hydroxytryptamine). Our preliminary data suggest that 5-HT regulates embryonic ChP calcium
activity, transcription, and vesicle release, and that intact signaling via the 5HT2C receptor in ChP is
essential for normal cerebral cortical development. Further, maternal delivery of a selective agonist for the
5HT2C receptor triggers rapid, robust immediate early gene expression in embryonic ChP. Thus, we propose
that ChP calcium activity triggered by signals that activate the 5HT2C receptor (and other receptors such
as TRPM3) regulates ChP transcription and secretion of signaling factors into the CSF and controls
body-brain and maternal-fetal interactions, thereby tightly orchestrating cerebral cortical development.
To test this, we will first investigate the effects of 5HT2C and TRPM3 receptor activation by direct application of
ligand to the apical surface of epithelial cells during calcium imaging in ChP explants (Aim 1a) and by stimulation
of the basal surface following intraperitoneal (IP) delivery of ligands to the maternal dam during in vivo two-
photon calcium imaging of attached embryos (Aim 1b). We then assess the transcriptomic impact of such
stimulation (Aim 1c), and test whether embryonic ChP calcium activity via activation of 5HT2C receptors and
other receptors triggers vesicle release and protein secretion in vitro (Aim 2a) and in vivo (Aim 2b). We will also
analyze the effects of disruption of ChP receptor signaling on cortical development (Aim 3a). Disrupted CSF
volume, composition, and ventricle formation are common to many neurological conditions. Perturbations in
maternal-fetal health can disrupt brain development, in part via dysregulation of serotonergic and other signaling
pathways. Our findings provide a novel platform for elucidating the mechanisms underlying dysregulation of brain
development by environmental perturbations, thereby providing a conceptual and technical roadmap for future
studies on how activity in ChP epithelial cells influences gene expression and protein secretion, with
consequences for many neurodevelopmental diseases.
项目概要/摘要
构建大脑皮层需要跨神经元的分子信号的空间和时间编排
祖细胞。这些细胞中的每一个都沐浴在脑脊液(CSF)中,这是一种富含健康和生长物质的介质
在大脑发育过程中,促进其成分在几天内发生深刻变化的因素。脉络膜
神经丛(ChP)可能对脑脊液成分的动态发育调节有很大贡献,但是
根本机制尚不清楚。在这里,我们将使用一套现代工具来测试
假设胚胎 ChP 上皮细胞中的钙浓度升高是对
外在信号对于调节信号因子合成和分泌到脑脊液中至关重要。钙
活性调节从神经元到唾液腺上皮细胞等多种细胞的转录和分泌。我们
鉴定出在 ChP 上皮细胞中表达的介导钙进入细胞的受体,例如 TRPM3
受体,或驱动内部储存的钙释放,例如血清素的 5HT2C 受体 (Htr2c)(5-
HT,5-羟色胺)。我们的初步数据表明 5-HT 调节胚胎 ChP 钙
活性、转录和囊泡释放,并且 ChP 中通过 5HT2C 受体的完整信号传导是
对于大脑皮层的正常发育至关重要。此外,母体递送选择性激动剂
5HT2C 受体触发胚胎 ChP 中快速、稳健的早期基因表达。因此,我们建议
ChP 钙活性由激活 5HT2C 受体(以及其他受体,例如
TRPM3)调节 ChP 转录和信号因子分泌到 CSF 中并控制
身体-大脑和母体-胎儿的相互作用,从而紧密协调大脑皮层的发育。
为了测试这一点,我们将首先通过直接应用来研究 5HT2C 和 TRPM3 受体激活的影响
ChP 外植体钙成像过程中(目标 1a)和刺激作用下上皮细胞顶端表面的配体
在体内两次腹膜内(IP)将配体递送至母体后基底表面的
附着胚胎的光子钙成像(目标 1b)。然后我们评估此类的转录组影响
刺激(目标 1c),并测试胚胎 ChP 钙活性是否通过激活 5HT2C 受体和
其他受体在体外(目标 2a)和体内(目标 2b)触发囊泡释放和蛋白质分泌。我们还将
分析 ChP 受体信号传导破坏对皮质发育的影响(目标 3a)。脑脊液受损
体积、组成和心室形成对于许多神经系统疾病来说是常见的。扰动
母婴健康可能会扰乱大脑发育,部分原因是血清素能和其他信号传导失调
途径。我们的研究结果为阐明大脑失调的机制提供了一个新的平台
环境扰动的发展,从而为未来提供概念和技术路线图
研究 ChP 上皮细胞的活性如何影响基因表达和蛋白质分泌,
许多神经发育疾病的后果。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cerebrospinal Fluid Magnetic Resonance Imaging: Improving Early Diagnosis of Autism and Other Neurodevelopmental Conditions.
脑脊液磁共振成像:改善自闭症和其他神经发育疾病的早期诊断。
- DOI:10.1016/j.bpsc.2020.05.007
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Xu,Huixin;Lehtinen,MariaK
- 通讯作者:Lehtinen,MariaK
Development and functions of the choroid plexus-cerebrospinal fluid system.
- DOI:10.1038/nrn3921
- 发表时间:2015-08
- 期刊:
- 影响因子:0
- 作者:Lun MP;Monuki ES;Lehtinen MK
- 通讯作者:Lehtinen MK
Progressive Differentiation and Instructive Capacities of Amniotic Fluid and Cerebrospinal Fluid Proteomes following Neural Tube Closure.
- DOI:10.1016/j.devcel.2015.11.015
- 发表时间:2015-12-21
- 期刊:
- 影响因子:11.8
- 作者:Chau KF;Springel MW;Broadbelt KG;Park HY;Topal S;Lun MP;Mullan H;Maynard T;Steen H;LaMantia AS;Lehtinen MK
- 通讯作者:Lehtinen MK
Disruption of GMNC-MCIDAS multiciliogenesis program is critical in choroid plexus carcinoma development.
- DOI:10.1038/s41418-022-00950-z
- 发表时间:2022-08
- 期刊:
- 影响因子:12.4
- 作者:Li Q;Han Z;Singh N;Terré B;Fame RM;Arif U;Page TD;Zahran T;Abdeltawab A;Huang Y;Cao P;Wang J;Lu H;Lidov HGW;Surendran K;Wu L;Virga JQ;Zhao YT;Schüller U;Wechsler-Reya RJ;Lehtinen MK;Roy S;Liu Z;Stracker TH;Zhao H
- 通讯作者:Zhao H
Antibodies Expand the Scope of Angiotensin Receptor Pharmacology.
抗体扩大了血管紧张素受体药理学的范围。
- DOI:10.1101/2023.08.23.554128
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Skiba,MeredithA;Sterling,SarahM;Rawson,Shaun;Gilman,MorganSA;Xu,Huixin;Nemeth,GenevieveR;Hurley,JosephD;Shen,Pengxiang;Staus,DeanP;Kim,Jihee;McMahon,Conor;Lehtinen,MariaK;Wingler,LauraM;Kruse,AndrewC
- 通讯作者:Kruse,AndrewC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIA LEHTINEN其他文献
MARIA LEHTINEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIA LEHTINEN', 18)}}的其他基金
Targeting the Choroid Plexus-Cerebrospinal Fluid System to Treat Post-Hemorrhagic Hydrocephalus
靶向脉络丛-脑脊液系统治疗出血后脑积水
- 批准号:
10566130 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
Control of neural stem cells by the nascent cerebrospinal fluid
新生脑脊液对神经干细胞的控制
- 批准号:
8765073 - 财政年份:2014
- 资助金额:
$ 64.31万 - 项目类别:
Control of neural stem cells by the nascent cerebrospinal fluid
新生脑脊液对神经干细胞的控制
- 批准号:
9267541 - 财政年份:2014
- 资助金额:
$ 64.31万 - 项目类别:
Control of neural stem cells by the nascent cerebrospinal fluid
新生脑脊液对神经干细胞的控制
- 批准号:
9491936 - 财政年份:2014
- 资助金额:
$ 64.31万 - 项目类别:
Activity-dependent Regulation of the Choroid Plexus-Cerebrospinal Fluid Stem Cell Niche
脉络丛-脑脊液干细胞生态位的活动依赖性调节
- 批准号:
10411898 - 财政年份:2014
- 资助金额:
$ 64.31万 - 项目类别:
Activity-dependent regulation of the choroid plexus-cerebrospinal fluid stem cell niche
脉络丛-脑脊液干细胞生态位的活动依赖性调节
- 批准号:
9980554 - 财政年份:2014
- 资助金额:
$ 64.31万 - 项目类别:
Cerebrospinal fluid proteome mediated signaling in the developing CNS
发育中的中枢神经系统中脑脊液蛋白质组介导的信号传导
- 批准号:
8599494 - 财政年份:2010
- 资助金额:
$ 64.31万 - 项目类别:
Cerebrospinal fluid proteome mediated signaling in the developing CNS
发育中的中枢神经系统中脑脊液蛋白质组介导的信号传导
- 批准号:
8028164 - 财政年份:2010
- 资助金额:
$ 64.31万 - 项目类别:
Cerebrospinal fluid proteome mediated signaling in the developing CNS
发育中的中枢神经系统中脑脊液蛋白质组介导的信号传导
- 批准号:
8402006 - 财政年份:2010
- 资助金额:
$ 64.31万 - 项目类别:
Cerebrospinal fluid proteome mediated signaling in the developing CNS
发育中的中枢神经系统中脑脊液蛋白质组介导的信号传导
- 批准号:
8129458 - 财政年份:2010
- 资助金额:
$ 64.31万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 64.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 64.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 64.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




